ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CBM Cambrex Corp

59.99
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cambrex Corp NYSE:CBM NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 59.99 0 01:00:00

Cambrex to Present at Upcoming Investor Conferences in September

26/08/2016 2:40pm

GlobeNewswire Inc.


Cambrex (NYSE:CBM)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Cambrex Charts.

Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), is pleased to announce that company management will present at the following investor conferences in September:

     2016 Wells Fargo Healthcare Conference
     Date:  Wednesday, September 7, 2016
      Time:  3:30 p.m. EDT
      Location:  Boston, MA
      
     Baird 2016 Global Healthcare Conference
     Date:  Thursday, September 8, 2016
     Time:  2:00 p.m. EDT
     Location:  New York, NY
      

The live audio webcasts and slide presentations can be accessed from the Cambrex website at www.cambrex.com in the Investors section under “Webcasts & Presentations”, and replays will be available for 90 days after the live events conclude. 

About CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.

Contact:
Stephanie LaFiura
Investor Relations Associate
Phone:  201.804.3037
Email:  stephanie.lafiura@cambrex.com

1 Year Cambrex Chart

1 Year Cambrex Chart

1 Month Cambrex Chart

1 Month Cambrex Chart

Your Recent History

Delayed Upgrade Clock